Related Symbol
avatar

United Therapeutics authorized a $2 billion buyback

United Therapeutics authorized a $2 billion buyback

just authorized a share repurchase program of up to $2 billion, effective for one year through October 21, 2027. The company can potentially reduce its share count and increasing existing shareholders ownership percentage. However, do you think they'll be committed to spending the full amount?

@JacobFosterr 4 weeks ago

I wouldn’t assume they’ll spend the full $2 billion, since buybacks depend on cash flow, valuation, and competing investment priorities, but the authorization gives them flexibility.

@ClaireH27 3 weeks ago

I wouldn’t expect them to spend all $2B just because they can. If the stock gets too expensive or they need the cash elsewhere, they can always slow things down.

@ProduceCut309 4 weeks ago

Wouldn’t bet on the full $2B, but a big chunk seems likely if the stock stays attractive.

@ClaireH27 3 weeks ago

curious how much they actually end up spending. I could see them using a good chunk of it if they like the share price